Task force recommendations didn't change federal policy, HHS secretary saysNovember 18th, 2009 more images
more imagesHHS secretary says mammograms still vitalWASHINGTON — Health and Human Services Secretary Kathleen Sebelius says federal policy on who should get breast cancer screening has not changed. Sebelius issued a statement Wednesday to ease confusion over a government panel's recommendation on Monday that said most women don't need mammograms in their 40s and should get one every two years starting at 50.
Firestorm follows US panel's ruling on mammogramsNovember 18th, 2009 WASHINGTON - The US government moved Wednesday to quell a rising fury over the findings of an official panel that mammograms were no longer necessary for women in their 40s and that older women should have fewer tests for breast cancer. US Secretary of Health and Human Services Kathleen Sebelius indicated that women should ignore the panel's findings, but she stopped short of criticising or countermanding the panel's work.
HHS secretary Sebelius says women should continue getting mammograms starting at age 40November 18th, 2009 more images
more images
Sebelius: Women should get mammograms by age 40
WASHINGTON — Women should continue getting regular mammograms starting at age 40, Health and Human Services Secretary Kathleen Sebelius said Wednesday, moving to douse confusion caused by a task-force recommendation two days earlier. Sebelius issued her statement following a government panel's recommendation on Monday, that said most women don't need mammograms in their 40s and should get one every two years starting at 50.
Now what do I do? Suddenly women in their 40s must ponder whose mammography advice to followNovember 17th, 2009 more images
more imagesNew mammogram advice raises questions, concernsNEW YORK — For many women, getting a mammogram is already one of life's more stressful experiences. Now, women in their 40s have the added anxiety of trying to figure out if they should even be getting one at all.
FDA panel questions long-term safety and effectiveness of Zimmer spine repair deviceNovember 4th, 2009 FDA panel has questions about Zimmer spine implantGAITHERSBURG, Md. — Federal health officials say there are lingering questions about whether an implant from Zimmer Holdings Inc.
Advisory panel recommends a second cervical cancer vaccine for girls and young womenOctober 21st, 2009 Panel recommends 2nd cervical cancer vaccineATLANTA — A federal vaccine advisory panel has voted to recommend a second vaccine against cervical cancer for girls and young women. The government last week licensed the vaccine, Cervarix from GlaxoSmithKline, for marketing in the United States.
FDA rejects labeling claims on vitamin C-enhanced version of Vicks NyquilOctober 14th, 2009 FDA warns P&G for adding vitamin C to NyquilWASHINGTON — Federal drug regulators are scolding Procter & Gamble for adding Vitamin C to its Vicks cold formulas, a combination not allowed by federal regulations. The Food and Drug Administration issued a warning to the consumer products company, saying medications like Vicks Nyquil and Dayquil have not been approved to contain vitamin C.
Nicaraguan women may soon get mammograms, health info at the bank thanks to Seattle nonprofitsOctober 9th, 2009 Nonprofits team up to bring mammograms to the bankSEATTLE — Women in Nicaragua may soon get mammograms and other health services at the bank, thanks to the work of two Seattle nonprofit groups. Global Partnerships, which supports services for the poor, is working with global-health expert PATH to launch the program with Pro Mujer (moo-HEHR').
Rite Aid changes flu-shot policy; pregnant women can get vaccine without doctor's noteOctober 8th, 2009 Rite Aid alters flu-shot policy for pregnant womenHARRISBURG, Pa. — The nation's third-largest drugstore chain is no longer making pregnant women show a prescription to get a flu shot.
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medicationOctober 5th, 2009 FDA panel backs Schering-Plough cancer drugGAITHERSBURG, Md. — Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer.
FDA panel back approval for abuse-resistant OxyContin pillSeptember 24th, 2009 FDA panel backs reformulated OxyContin pillWASHINGTON — Federal health advisers on Thursday recommended approval for a new version of the painkiller OxyContin that is designed to be harder to abuse. A Food and Drug Administration panel of experts voted 14-4 in favor of the reformulated OxyContin from Purdue Pharma.
Federal officials issue guidelines to help small businesses weather swine fluSeptember 14th, 2009 Feds urge small businesses to prepare for H1N1WASHINGTON — Federal officials say small business owners should be prepared to operate with fewer employees this fall as swine flu spreads across the country. The Department of Homeland Security is issuing guidelines on combating swine flu to small businesses, which employ about half the workers in the U.S.
FDA panel says Merck vaccine for cervical cancer Gardasil blocks genital warts in malesSeptember 9th, 2009 FDA panel backs Gardasil for use by menWASHINGTON — Federal health advisers say Merck's vaccine Gardasil, which already is used to prevent cervical cancer in women, should also be approved to stop genital warts in men. A Food and Drug Administration panel voted unanimously with one abstention that the vaccine is effective for blocking the human papilloma virus, or HPV, in males ages 9 to 26.
HHS Secretary Sebelius announces new food safety Web site designed to streamline food infoSeptember 9th, 2009 Sebelius announces new food safety Web siteWASHINGTON — The Obama administration is rolling out a new Web site designed to streamline food safety information for consumers. Health and Human Services Secretary Kathleen Sebelius announced the new Web site — www.foodsafety.gov — on Wednesday during the Consumer Federation of America's food policy conference.
FDA panel says Allos Therapeutics drug will benefit patients with rare form of lymphomaSeptember 2nd, 2009 FDA panel backs Allos Therapeutics' cancer drugWASHINGTON — Federal health experts voted Wednesday in favor of an experimental cancer drug from Allos Therapeutics for patients with a rare form of cancer. A spokeswoman for the Food and Drug Administration said the agency's panel of oncology experts voted 10-4 that the company's drug pralatrexate would likely benefit patients with T-Cell lymphoma.
November 18th, 2009 at 6:04 pm
The question has to be asked as to whether the reasoning for the panel’s recommendations was based on trying to achieve cost containment or based on scientific analysis that shows little benefit from the screening?